市場調查報告書 - 224808

美國的傳染病檢查市場預測:成長機會及產業擴大策略

US Infectious Disease Testing Market Outlook: Innovations, Trends and Opportunities for Suppliers

出版商 Venture Planning Group
出版日期 2013年05月16日 內容資訊 英文
價格
美國的傳染病檢查市場預測:成長機會及產業擴大策略 US Infectious Disease Testing Market Outlook: Innovations, Trends and Opportunities for Suppliers
出版日期: 2013年05月16日 內容資訊: 英文
簡介

本報告提供美國的傳染病檢查市場相關調查分析,提供全球市場及技術概要,美國市場現況與今後十年間的未來預測,主要的產品開發機會,打入市場策略等驗證,也包含主要企業簡介,為您概述為以下內容。

簡介

全球市場及技術概要

  • 主要的傳染病檢查
    • 愛滋病
    • 腺病毒
    • 產氣單胞菌
    • 炭疽病
    • 蟲媒病毒
    • 犬焦蟲症
    • 桿菌性血骨病•巴通氏菌傳染病
    • 人芽囊原蟲感染症
    • 布氏桿菌症
    • 曲狀桿菌症
    • 念珠菌感染
    • 南美錐蟲病
    • 軟性下疳
    • 披衣菌感染
    • 艱難梭狀芽胞桿菌感染症
    • 犬冠狀病毒
    • 克沙奇病毒等等
  • 設備評估和市場需求
  • 新興診斷技術
    • (DNA)核酸探針
    • 單株抗體
    • 免疫測量
    • 光散射分析
    • 微電腦與自動化
    • 人工智能
    • 微脂體
    • 流式細胞技術
    • 層析法
    • MRI
    • 凝膠微滴法
    • 其他

美國市場

  • 摘要整理
  • 商務環境
  • 市場結構
  • 市場規模與成長,主要業者

主要的產品開發機會

  • 設備
  • 試劑組和檢查系統/操作面板
  • 電腦,軟體,自動化
  • 輔助產品

分散式檢查產品的設計標準

打入市場策略

  • 國內開發
  • 共同開發
  • 與大學的契約
  • 流通策略

潛在的打入市場的障礙與風險

  • 市場成熟度
  • 成本控制
  • 競爭
  • 在技術方面的優勢與限制
  • 專利保護
  • 法規限制
  • 分散式檢查市場課題

競爭企業各公司的評估

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Table of Contents

Introduction

Worldwide Market and Technology Overview

  • A. Major Infectious Disease Tests
    • 1. AIDS
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 2. Adenovirus
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
      • d. Adeno-Associated Viruses(AAV)
    • 3. Aeromonas
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 4. Anthrax/Bacillus Anthracis
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 5. Arboviruses
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 6. Babesiosis
      • a. Background
    • 7. Bacillary Epithelioid Angiomatosis (BEA) And Other Bartonella (Rochalimaea)
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 8. Blastocystis Hominis
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 9. Brucella
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 10. Campylobacter
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 11. Candida
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 12. Chagas Disease
      • a. Background
    • 13. Chancroid
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 14. Chlamydia
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 15. Clostridium Difficile
      • a. Background
      • b. Diagnostic Tests
      • c. Drugs and Vaccines
    • 16. Coronaviruses
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 17. Coxsackieviruses
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 18. Creutzfeldt-Jakob's Disease
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines
    • 19. Cryptosporidium Parvum
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 20. Cyclospora Cayetanensis
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 21. Cytomegalovirus
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 22. Ebola Virus
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 23. E. Coli
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 24. EchoVirus
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 25. Encephalitis
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 26. Enteroviruses
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 27. Epstein-Barr Virus
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 28. Giardia Lamblia
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 29. Gonorrhea
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 30. Granuloma Inguinale
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 31. Hantavirus
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 32. Helicobacter Pylori
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 33. Hepatitis
      • a. Background
      • b. Hepatitis A
      • c. Hepatitis B
      • d. Hepatitis C
      • e. Vaccines and Drugs
    • 34. Herpes Simplex Virus
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 35. Human Herpes Virus-6 (HHV-6)
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 36. Influenza Viruses
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 37. Legionella
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 38. Lyme Disease
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 39. Lymphogranuloma Venereum (LGV)
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 40. Malaria
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 41. Measles (Rubeola)
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 42. Meningitis
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 43. Microsporidium
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 44. Mononucleosis
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 45. Mumps
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 46. Mycoplasma
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 47. Papillomaviruses
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 48. Parvovirus B19
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 49. Pneumonia
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 50. Polyomaviruses
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 51. Pseudomonas Aeruginosa
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 52. Rabies
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 53. Respiratory Syncytial Virus (RSV)
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 54. RhinoViruses
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 55. RotaVirus (REOVIRUS)
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 56. Rubella(MEASLES)
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 57. Salmonellosis
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 58. Septicemia
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 59. Shigellosis
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 60. Staphylococcus Aureus
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 61. Streptococci
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 62. Syphilis
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 63. Toxoplasmosis
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 64. Trichomonas Vaginalis
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 65. Tuberculosis
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 66. Vibrio
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 67. West Nile Virus
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 68. Yersina
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
  • B. Instrumentation Review of Leading Analyzers Marketed by Abbott, Beckman Coulter/Danaher, BioMerieux, Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other Suppliers
  • C. Emerging Diagnostic Technologies
    • 1. Molecular Diagnostics
    • 2. Monoclonal Antibodies
    • 3. Immunoassays
    • 4. Differential Light Scattering
    • 5. Information Technology
    • 6. Artificial Intelligence
    • 7. Liposomes
    • 8. Flow Cytometry
    • 9. Chromatography
    • 10. Diagnostic Imaging
    • 11. Gel Microdroplets
    • 12. Other

U.S.A.

  • A. Executive Summary
  • B. Business Environment
    • 1. Health Care Expenditures
    • 2. Cost Consciousness
    • 3. Reimbursement
    • 4. Industry Consolidation
    • 5. Managed Care
    • a. HMO
    • b. PPO
    • 6. Hospitals
    • 7. Admissions
    • 8. Length of Stay
    • 9. Industry Diversification
    • 10. Physician Demographics
    • 11. Population Aging
      • a. Chronic Illness
      • b. Disease Incidence
      • c. Susceptibility to Iatrogenesis
      • d. Multiple Illness Cases
    • 12. Laboratory Regulations
    • 13. FDA Reform
  • C. Market Structure
    • 1. Centralized Testing
      • a. Hospitals
      • b. Commercial/Private Laboratories
      • c. Blood Banks
        • 1) Community and Regional Centers
        • 2) Plasma Fractionation Centers
    • 2. Decentralized Testing
      • a. Physician Offices/Group Practices
      • b. Point of Care Testing
      • c. Other Decentralized Testing Locations
  • D. Market Size, Growth and Major Suppliers

Major Product Development Opportunities

  • A. Instrumentation
  • B. Reagent Kits and Test Systems/Panels
  • C. Computers, Software and Automation
  • D. Auxiliary Products

Design Criteria for Decentralized Testing Products

Alternative Market Penetration Strategies

  • A. Internal Development
  • B. Collaborative Arrangements
  • C. University Contracts
  • D. Distribution Strategies for Decentralized Testing Markets
    • 1. Marketing Approaches
    • 2. Product Complexity
    • 3. Customer Preference
    • 4. Established Suppliers
    • 5. Emerging Suppliers
    • 6. Major Types of Distributors
    • 7. Market Segmentation

Potential Market Entry Barriers and Risks

  • A. Market Maturity
  • B. Cost Containment
  • C. Competition
  • D. Technological Edge and Limitations
  • E. Patent Protection
  • F. Regulatory Constraints
  • G. Decentralized Testing Market Challenges

Competitive Assessments

  • Abbott
  • Affymetrix
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • bioMerieux
  • Bio-Rad
  • Cepheid
  • Diamedix
  • DiaSorin
  • Eiken Chemical
  • Enzo Biochem
  • Fujirebio
  • Gen-Probe
  • Hologic
  • ID Biomedical
  • Innogenetics/Solvay
  • Kreatech
  • Life Technology
  • Lonza
  • Nanogen/Elitech
  • Novartis Diagnostics
  • Ortho-Clinical Diagnostics
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • SeraCare
  • Siemens
  • Takara Bio
  • Thermo Fisher
  • Wallac
  • Wako

List of Tables

  • Major Companies Developing or Marketing AIDS Tests
  • Major Companies Developing or Marketing Adenovirus Tests
  • Major Companies Developing or Marketing Bartonella Tests
  • Major Companies Developing or Marketing Campylobacter Tests
  • Major Companies Developing or Marketing Candida Tests
  • Major Companies Developing or Marketing Chlamydia Tests
  • Major Companies Developing or Marketing Clostridium Tests
  • Major Companies Developing or Marketing Coronavirus Tests
  • Major Companies Developing or Marketing Cryptosporidium Tests
  • Major Companies Developing or Marketing CMV Tests
  • Major Companies Developing or Marketing Echovirus Tests
  • Major Companies Developing or Marketing Enterovirus Tests
  • Major Companies Developing or Marketing EBV Tests
  • Major Companies Developing or Marketing Giardia Tests
  • Major Companies Developing or Marketing Gonorrhea Tests
  • Major Companies Developing or Marketing Hantavirus Tests
  • Major Companies Developing or Marketing Helicobacter Pylori Tests
  • Major Companies Developing or Marketing Hepatitis Tests
  • Major Companies Developing or Marketing Herpes Tests
  • Major Companies Developing or Marketing Influenza Tests
  • Major Companies Developing or Marketing Legionella Tests
  • Major Companies Developing or Marketing Lyme Disease Tests
  • Major Companies Developing or Marketing Lymphogranuloma Tests
  • Major Companies Developing or Marketing Malaria Tests
  • Major Companies Developing or Marketing Measles Tests
  • Major Companies Developing or Marketing Meningitis Tests
  • Major Companies Developing or Marketing Microsporidium Tests
  • Major Companies Developing or Marketing Mononucleosis Tests
  • Major Companies Developing or Marketing Mumps Tests
  • Major Companies Developing or Marketing Mycoplasma Tests
  • Major Companies Developing or Marketing Papilloma Virus Tests
  • Major Companies Developing or Marketing Parvovirus Tests
  • Major Companies Developing or Marketing Pneumonia Tests
  • Major Companies Developing or Marketing RSV Tests
  • Major Companies Developing or Marketing Rotavirus Tests
  • Major Companies Developing or Marketing Rubella Tests
  • Major Companies Developing or Marketing Salmonella Tests
  • Major Companies Developing or Marketing Septicemia Tests
  • Major Companies Developing or Marketing Shigella Tests
  • Major Companies Developing or Marketing Staphylococci Tests
  • Major Companies Developing or Marketing Streptococci Tests
  • Major Companies Developing or Marketing Syphilis Tests
  • Major Companies Developing or Marketing Toxoplasmosis Tests
  • Major Companies Developing or Marketing Trichomonas Tests
  • Major Companies Developing or Marketing Tuberculosis Tests
  • Major Companies Developing or Marketing West Nile Tests
  • Major Companies Developing or Marketing Yersinia Tests
  • U.S.A. Summary Table
  • All Infectious Diseases Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Laboratories Performing Infectious Disease Tests by Market Segment
  • U.S.A. Hospital Laboratories Performing Infectious Disease Tests by Bed Size
  • U.S.A. Commercial/Private Laboratories Performing Infectious Disease Tests by Annual Test Volume
  • U.S.A. Physician Office Laboratories Performing Infectious Disease Tests by Practice Size
  • U.S.A. All Market Segments Infectious Disease Test Volume Forecast
  • U.S.A. Hospital Laboratories Infectious Disease Test Volume Forecast
  • U.S.A. Blood Banks Infectious Disease Test Volume Forecast
  • U.S.A. Physician Office Laboratories Infectious Disease Test Volume Forecast
  • U.S.A. Commercial/Private Laboratories Infectious Disease Test Volume Forecast
  • U.S.A. Public Health Laboratories Infectious Disease Test Volume Forecast
  • U.S.A. All Market Segments Infectious Disease Diagnostics Market Forecast
  • U.S.A. Hospital Laboratories Infectious Disease Diagnostics Market Forecast
  • U.S.A. Blood Banks Infectious Disease Diagnostics Market Forecast
  • U.S.A. Physician Office Laboratories Infectious Disease Diagnostics Market Forecast
  • U.S.A. Commercial/Private Laboratories Infectious Disease Diagnostics Market Forecast
  • U.S.A. Public Health Laboratories Infectious Disease Diagnostics Market Forecast
  • U.S.A. HIV or HIV I/HIV II Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. HIVAg Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Western Blot/Other Confirmatory Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Adenovirus Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Aeromonads Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. BEA Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Blastocystis Hominis Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Campylobacter Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Candida Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Clostridium Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Coronavirus Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. CoxsackieVirus Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Cryptosporidium Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Cyclospora Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. CMV Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. E. Coli Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Echovirus Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Encephalitis Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Enterovirus Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. EBV Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Giardia Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Gonorrhea Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Granuloma Inguinale Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Hantavirus Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Helicobacter Pylori Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. HAV NAT Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. HBV NAT Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. HbsAg Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Hepatitis C Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Anti-HBC Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Anti-HBS Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Anti-HAV Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Hepatitis Delta Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. HBcAg Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. HBeAg Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. ALT/SGPT Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. HTLV I or HTLV I/HTLV II Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Influenza Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Legionella Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Lyme Disease Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Lymphogranuloma Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Malaria Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Measles Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Meningitis Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Microsporidium Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Mononucleosis Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Mumps Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Papilloma Virus Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Parvovirus Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Pneumonia Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Polyomaviruses Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Pseudomonas Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Rabies Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. RSV Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Rhinovirus Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Rotavirus Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Rubella Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Salmonella Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Septicemia Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Shigella Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Staphylococci Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Streptococci Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Syphilis Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Toxoplasmosis Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Trichomonas Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Tuberculosis Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Vibrio Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. West Nile Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Yersinia Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. AIDS Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Adenovirus Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Campylobacter Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Candida Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Chancroid Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Chlamydia Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. CMV Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Cryptosporidium Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Echovirus Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Enterovirus Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. EBV Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Giardia Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Gonorrhea Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Helicobacter Pylori Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Hepatitis Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Hepatitis C Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Herpes Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Influenza Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Legionella Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Lyme Disease Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Measles Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Meningitis Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Mononucleosis Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Mumps Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Mycoplasma Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Pneumonia Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Rabies Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. RSV Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Rotavirus Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Rubella Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Salmonella Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Septicemia Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Shigella Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Streptococci Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Syphilis Testing Market Diagnostics Sales by Major Supplier
  • U.S.A. Toxoplasmosis Testing Market Diagnostics Sales by Major Supplier

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

美國的傳染病檢查市場預測:成長機會及產業擴大策略是由出版商Venture Planning Group在2013年05月16日所出版的。這份市場調查報告書價格從美金6400起跳。

Back to Top
;